Warning: The NCBI web site requires JavaScript to function. more...
A dual role of Cdk2 in DNA damage response.
Satyanarayana A, Kaldis P.
Cell Div. 2009 May 18;4:9.
Related citations
p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint.
Satyanarayana A, Hilton MB, Kaldis P.
Mol Biol Cell. 2008 Jan;19(1):65-77. Epub 2007 Oct 17.
S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.
Hu B, Mitra J, van den Heuvel S, Enders GH.
Mol Cell Biol. 2001 Apr;21(8):2755-66.
Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.
Oncogene. 2009 Aug 20;28(33):2925-39. Epub 2009 Jun 29. Review.
Cdk2 and Cdk4 cooperatively control the expression of Cdc2.
Berthet C, Kaldis P.
Cell Div. 2006 Jun 6;1:10.
Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo.
Moreau JL, Marques F, Barakat A, Schatt P, Lozano JC, Peaucellier G, Picard A, Genevière AM.
Dev Biol. 1998 Aug 15;200(2):182-97.
Cdk2 as a master of S phase entry: fact or fake?
Aleem E, Berthet C, Kaldis P.
Cell Cycle. 2004 Jan;3(1):35-7. Review.
CDK2 and FOXO1: a fork in the road for cell fate decisions.
Huang H, Tindall DJ.
Cell Cycle. 2007 Apr 15;6(8):902-6. Epub 2007 Apr 5.
The cyclin E/Cdk2 substrate p220(NPAT) is required for S-phase entry, histone gene expression, and Cajal body maintenance in human somatic cells.
Ye X, Wei Y, Nalepa G, Harper JW.
Mol Cell Biol. 2003 Dec;23(23):8586-600.
Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints.
Chow JP, Siu WY, Ho HT, Ma KH, Ho CC, Poon RY.
J Biol Chem. 2003 Oct 17;278(42):40815-28. Epub 2003 Aug 11.
Histone acetylation and the cell-cycle in cancer.
Wang C, Fu M, Mani S, Wadler S, Senderowicz AM, Pestell RG.
Front Biosci. 2001 Apr 1;6:D610-29. Review.
Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2.
Satyanarayana A, Berthet C, Lopez-Molina J, Coppola V, Tessarollo L, Kaldis P.
Development. 2008 Oct;135(20):3389-400. Epub 2008 Sep 11.
Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
Bilodeau JF, Faure R, Piedboeuf B, Mirault ME.
Exp Cell Res. 2000 May 1;256(2):347-57.
Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM, Lents NH, Baldassare JJ.
J Biol Chem. 2004 Feb 13;279(7):5387-96. Epub 2003 Nov 25.
Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers.
Deans AJ, Khanna KK, McNees CJ, Mercurio C, Heierhorst J, McArthur GA.
Cancer Res. 2006 Aug 15;66(16):8219-26.
Cdk2 inhibition prolongs G1 phase progression in mouse embryonic stem cells.
Koledova Z, Kafkova LR, Calabkova L, Krystof V, Dolezel P, Divoky V.
Stem Cells Dev. 2010 Feb;19(2):181-94.
Cdk2 knockout mice are viable.
Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P.
Curr Biol. 2003 Oct 14;13(20):1775-85.
Ectopic expression of human Cdk2 and its yeast homolog, Ime2, is deleterious to Saccharomyces cerevisiae.
Szwarcwort-Cohen M, Gurevich V, Sagee S, Kassir Y.
Cell Cycle. 2010 Dec 1;9(23):4711-9. Epub 2010 Dec 1.
Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.
He G, Siddik ZH, Huang Z, Wang R, Koomen J, Kobayashi R, Khokhar AR, Kuang J.
Oncogene. 2005 Apr 21;24(18):2929-43.
Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints.
Kaufmann WK.
Proc Soc Exp Biol Med. 1998 Mar;217(3):327-34. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on